BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT05822219 updates: 1. completion date: 2027-03-30 → 2027-12-31 2. primary completion date: 2026-03-31 → 2026-04-01 3. enrollment: not set → 60 participants
Clinical trial NCT05822219 updates: 1. completion date: 2027-03-30 → 2027-12-31 2. primary completion date: 2026-03-31 → 2026-04-01 3. enrollment: not set → 60 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical